[go: up one dir, main page]

TR200401036T1 - Yüksek kan basıncının tedavisi için citalopram. - Google Patents

Yüksek kan basıncının tedavisi için citalopram.

Info

Publication number
TR200401036T1
TR200401036T1 TR2004/01036T TR200401036T TR200401036T1 TR 200401036 T1 TR200401036 T1 TR 200401036T1 TR 2004/01036 T TR2004/01036 T TR 2004/01036T TR 200401036 T TR200401036 T TR 200401036T TR 200401036 T1 TR200401036 T1 TR 200401036T1
Authority
TR
Turkey
Prior art keywords
blood pressure
high blood
citalopram
treatment
normalizing
Prior art date
Application number
TR2004/01036T
Other languages
English (en)
Inventor
S. Gabor Pal
Original Assignee
Egis Gyogyzergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyzergyar Rt. filed Critical Egis Gyogyzergyar Rt.
Publication of TR200401036T1 publication Critical patent/TR200401036T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu buluş, citalopram veya bunun farmasötik açıdan kabul edilebilir bir tuzunun, yüksek kan basınıcının tedavi edilmesi, kan basıncının normalleştirilmesi veya kan basıncının düşürülmesi ve/veya yüksek kan basıncının önlenmesi için uygun farmasötik terkipler hazırlamak için kullanımı ile ilgilidir.
TR2004/01036T 2002-03-14 2003-03-13 Yüksek kan basıncının tedavisi için citalopram. TR200401036T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0200980A HU0200980D0 (tr) 2002-03-14 2002-03-14
PCT/HU2003/000021 WO2003075914A1 (en) 2002-03-14 2003-03-13 Citalopram for the treatment of elevated blood pressure

Publications (1)

Publication Number Publication Date
TR200401036T1 true TR200401036T1 (tr) 2005-10-21

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01036T TR200401036T1 (tr) 2002-03-14 2003-03-13 Yüksek kan basıncının tedavisi için citalopram.

Country Status (34)

Country Link
US (1) US7141604B2 (tr)
EP (1) EP1490049B1 (tr)
JP (1) JP2005519945A (tr)
KR (1) KR100718368B1 (tr)
CN (1) CN1259912C (tr)
AT (1) ATE324887T1 (tr)
AU (1) AU2003211195B2 (tr)
BG (1) BG108904A (tr)
BR (1) BR0303384A (tr)
CA (1) CA2459834A1 (tr)
CY (1) CY1106129T1 (tr)
CZ (1) CZ2004661A3 (tr)
DE (1) DE60305018T2 (tr)
DK (1) DK1490049T3 (tr)
EA (1) EA008350B1 (tr)
EE (1) EE200400069A (tr)
ES (2) ES2238939B2 (tr)
HR (1) HRP20040165B1 (tr)
HU (1) HU0200980D0 (tr)
IL (2) IL160486A0 (tr)
IS (1) IS2392B (tr)
LT (1) LT5255B (tr)
LV (1) LV13281B (tr)
MX (1) MXPA04008919A (tr)
NO (1) NO20034998D0 (tr)
PL (1) PL368902A1 (tr)
PT (1) PT1490049E (tr)
SI (1) SI1490049T1 (tr)
SK (1) SK2222004A3 (tr)
TR (1) TR200401036T1 (tr)
UA (1) UA77506C2 (tr)
WO (1) WO2003075914A1 (tr)
YU (1) YU91203A (tr)
ZA (1) ZA200408056B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2362561C2 (ru) * 2003-10-10 2009-07-27 Зольвай Фармасьютиклз Гмбх Фармацевтическая композиция, включающая селективный агонист имидазолинового рецептора i1 и блокатор рецептора ангиотензина ii
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
SK283309B6 (sk) * 1997-07-08 2003-05-02 H. Lundbeck A/S Spôsob výroby citalopramu a medziprodukty
ES2149734T3 (es) * 1997-11-11 2003-02-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
EA008350B1 (ru) 2007-04-27
DK1490049T3 (da) 2006-08-21
CA2459834A1 (en) 2003-09-18
SK2222004A3 (en) 2004-08-03
YU91203A (sh) 2006-08-17
HK1075390A1 (en) 2005-12-16
CN1568183A (zh) 2005-01-19
ES2263009T3 (es) 2006-12-01
CY1106129T1 (el) 2011-06-08
WO2003075914A1 (en) 2003-09-18
AU2003211195B2 (en) 2007-10-18
PL368902A1 (en) 2005-04-04
JP2005519945A (ja) 2005-07-07
EP1490049A1 (en) 2004-12-29
HRP20040165A2 (en) 2004-10-31
EA200401147A1 (ru) 2005-02-24
AU2003211195A1 (en) 2003-09-22
ES2238939A1 (es) 2005-09-01
BG108904A (en) 2006-04-28
US20050065209A1 (en) 2005-03-24
DE60305018D1 (de) 2006-06-08
KR100718368B1 (ko) 2007-05-14
CZ2004661A3 (cs) 2004-10-13
IS7418A (is) 2004-08-20
IS2392B (is) 2008-08-15
EP1490049B1 (en) 2006-05-03
MXPA04008919A (es) 2004-11-26
IL160486A (en) 2008-06-05
PT1490049E (pt) 2006-08-31
HU0200980D0 (tr) 2002-05-29
DE60305018T2 (de) 2006-11-30
UA77506C2 (en) 2006-12-15
ZA200408056B (en) 2005-10-10
EE200400069A (et) 2004-08-16
LT2004049A (en) 2005-03-25
LV13281B (en) 2005-09-20
HRP20040165B1 (hr) 2007-08-31
KR20040090949A (ko) 2004-10-27
IL160486A0 (en) 2004-07-25
SI1490049T1 (sl) 2006-10-31
ES2238939B2 (es) 2006-04-16
CN1259912C (zh) 2006-06-21
US7141604B2 (en) 2006-11-28
AU2003211195A2 (en) 2003-09-22
NO20034998D0 (no) 2003-11-10
ATE324887T1 (de) 2006-06-15
BR0303384A (pt) 2004-03-30
LT5255B (lt) 2005-08-25

Similar Documents

Publication Publication Date Title
DE50310516D1 (de) Fredericamycin-derivate
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
DK1044197T3 (da) Piperidinylsubstituerede pyridylalkan-, -alken- og -alkyncarboxamider som cytostatiske midler og immunosuppressive midler
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
EA200501310A1 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения боли
NO20050640L (no) Rutenium anticancer komplekser
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
TR200401036T1 (tr) Yüksek kan basıncının tedavisi için citalopram.
ATE429919T1 (de) Prophylaktische und therapeutische verwendung von hydroxysteroiden
DE602004030265D1 (de) Behandlung von gastrointestinalen stromatumoren mit imatinib und midostaurin
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
DE60120398D1 (de) Imidazopyridin-8-one
DE60216090D1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
ATE454144T1 (de) Behandlung von malignen neoplasien